title: The 'Birmingham Hypertension Square' for the optimum choice of add-in drugs in the management of resistant hypertension.
authors.affiliation: University Department of Medicine, City Hospital, Birmingham, UK.
authors.forename: G Y
authors.initials: GY
authors.lastname: Lip
authors.forename: M
authors.initials: M
authors.lastname: Beevers
authors.forename: D G
authors.initials: DG
authors.lastname: Beevers
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004232:Diuretics; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008962:Models, Theoretical; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors